NO985239L - Nye metalloproteinase inhibitorer, fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger inneholdende dem - Google Patents

Nye metalloproteinase inhibitorer, fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger inneholdende dem

Info

Publication number
NO985239L
NO985239L NO985239A NO985239A NO985239L NO 985239 L NO985239 L NO 985239L NO 985239 A NO985239 A NO 985239A NO 985239 A NO985239 A NO 985239A NO 985239 L NO985239 L NO 985239L
Authority
NO
Norway
Prior art keywords
alkyl
preparation
methods
pharmaceutical compositions
compositions containing
Prior art date
Application number
NO985239A
Other languages
English (en)
Other versions
NO311723B1 (no
NO985239D0 (no
Inventor
Guillaume De Nanteuil
Georges Remond
Joseph Paladino
Ghanem Atassi
Alain Pierre
Gordon Tucker
Jacqueline Bonnet
Massimo Sabatini
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO985239D0 publication Critical patent/NO985239D0/no
Publication of NO985239L publication Critical patent/NO985239L/no
Publication of NO311723B1 publication Critical patent/NO311723B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19985239A 1997-11-14 1998-11-10 Nye metalloproteinase inhibitorer, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem NO311723B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9714278A FR2771095B1 (fr) 1997-11-14 1997-11-14 Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO985239D0 NO985239D0 (no) 1998-11-10
NO985239L true NO985239L (no) 1999-05-18
NO311723B1 NO311723B1 (no) 2002-01-14

Family

ID=9513364

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985239A NO311723B1 (no) 1997-11-14 1998-11-10 Nye metalloproteinase inhibitorer, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem

Country Status (18)

Country Link
US (1) US6066633A (no)
EP (1) EP0916671B1 (no)
JP (1) JPH11209378A (no)
CN (1) CN1217332A (no)
AT (1) ATE212634T1 (no)
AU (1) AU740313B2 (no)
BR (1) BR9805014A (no)
CA (1) CA2254152C (no)
DE (1) DE69803648T2 (no)
DK (1) DK0916671T3 (no)
ES (1) ES2172101T3 (no)
FR (1) FR2771095B1 (no)
HU (1) HUP9802645A3 (no)
NO (1) NO311723B1 (no)
NZ (1) NZ332803A (no)
PL (1) PL329674A1 (no)
PT (1) PT916671E (no)
ZA (1) ZA9810411B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2821842B1 (fr) * 2001-03-07 2003-05-09 Servier Lab Nouveaux derives d'inhibiteurs de mettalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PE20030701A1 (es) * 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
ITMI20071163A1 (it) * 2007-06-08 2008-12-09 C4T S C A R L Arilsolfonammidi dela beta-carbolina metodo per prepararle e composizione che le comprende
CN104387382A (zh) 2008-03-24 2015-03-04 梅迪维新技术公司 吡啶并[3,4-b]吲哚和应用方法
CN101597289B (zh) * 2008-06-02 2011-09-21 首都医科大学 2-色氨酰-β-四氢咔啉-3-甲酰基氨基酸苄酯及其制备方法和应用
AU2010298167B2 (en) * 2009-09-23 2015-12-24 Medivation Technologies, Inc. Pyrido(3,4-b)indoles and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663178A (en) * 1995-02-06 1997-09-02 Eli Lilly And Company Tetrahydro-beta carbolines
BR9611479B1 (pt) * 1995-11-13 2009-01-13 Ácidos alfa-iminoidroxÂmicos e carboxÍlicos n-substituÍdos cÍclicos e heterocÍclicos.
FR2748026B1 (fr) * 1996-04-26 1998-06-05 Adir Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
FR2771095A1 (fr) 1999-05-21
FR2771095B1 (fr) 1999-12-17
PL329674A1 (en) 1999-05-24
AU9237798A (en) 1999-06-03
ES2172101T3 (es) 2002-09-16
JPH11209378A (ja) 1999-08-03
HUP9802645A3 (en) 2000-01-28
EP0916671A1 (fr) 1999-05-19
DE69803648T2 (de) 2002-10-31
PT916671E (pt) 2002-06-28
HUP9802645A2 (hu) 1999-07-28
NZ332803A (en) 1999-05-28
ATE212634T1 (de) 2002-02-15
EP0916671B1 (fr) 2002-01-30
HU9802645D0 (en) 1999-01-28
DK0916671T3 (da) 2002-03-25
DE69803648D1 (de) 2002-03-14
CN1217332A (zh) 1999-05-26
CA2254152A1 (fr) 1999-05-14
AU740313B2 (en) 2001-11-01
BR9805014A (pt) 2001-04-24
ZA9810411B (en) 1999-05-24
NO311723B1 (no) 2002-01-14
US6066633A (en) 2000-05-23
NO985239D0 (no) 1998-11-10
CA2254152C (fr) 2003-04-08

Similar Documents

Publication Publication Date Title
NO305988B1 (no) Nye pyridinforbindelser og farmasoeytiske sammensetninger som inneholder dem
HUT76064A (en) Fused pyrrolecarboxanilides
GR3033996T3 (en) 3-(Piperi-4-yl) 1,2-benzisoxazole and 3-(piperazin-4-yl) 1,2-benzisoxazole derivatives, processes for their preparation and pharmaceutical compositions containing them
ES2162857T3 (es) Derivados fenilicos trisustituidos utilizados como inhibidores de fosfodiesterasa.
NO953447L (no) Nye 4-aminopyridiner, fremgangsmåte for deres fremstilling samt legemidler inneholdende disse
MY131193A (en) 7-(2-aminoethyl)-benzothiazolones
CO5590924A2 (es) Derivados de indolilalquilamina como ligandos de 5- hidroxitriptamina-6
IE892189L (en) Derivatives of (aza) naphthalenesultam, their preparation¹and compositions containing them
NO940815D0 (no) Benzodiazepinderivater, deres fremstilling og medikamenter inneholdende derivatene
DK393486A (da) Dihydropyridin-derivater og fremgangsmaade til fremstilling deraf
NO985239D0 (no) Nye metalloproteinase inhibitorer, fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger inneholdende dem
NO933435L (no) Piperidinderivater, deres fremstilling og anvendelse
NO20003431D0 (no) Nye metalloproteaseinhibitorer, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
NO993608D0 (no) Nye 8H-tieno-[2,3-b]pyrrolizin-8-on forbindelser, fremgangsmåte ved deres fremstilling og farmasoeytiske sammensetninger inneholdende dem